newsfilter
← Latest News
PR Newswire·

Cellular Biomedicine Group Reports Second Quarter and First Half of 2019 Financial Results and Business Highlights

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...